CHEK1 and lymphoma: Treatment of a diverse range of leukemia and lymphoma cell lines with the selective Chk1 inhibitors V158411 or PF-477736 potently inhibited the proliferation of these cell lines and induced cell death that was both caspase-3/7 dependent and independent.